Skip to main navigation Skip to search Skip to main content

The copper binding properties of metformin - QCM-D, XPS and nanobead agglomeration

  • Xueling Quan (Lead / Corresponding author)
  • , Rokon Uddin
  • , Arto Heiskanen
  • , Mattias Parmvi
  • , Katharina Nilson
  • , Marco Donolato
  • , Mikkel F. Hansen
  • , Graham Rena
  • , Anja Boisen (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

Abstract

Study of the copper binding properties of metformin is important for revealing its mechanism of action as a first-line type-2 diabetes drug. A quantitative investigation of interactions between metformin and l-cysteine-copper complexes was performed. The results suggest that metformin could interact with biological copper, which plays a key role in mitochondrial function.

Original languageEnglish
Pages (from-to)17313-17316
Number of pages4
JournalChemical Communications
Volume51
Issue number97
DOIs
Publication statusPublished - 18 Dec 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The copper binding properties of metformin - QCM-D, XPS and nanobead agglomeration'. Together they form a unique fingerprint.

Cite this